About Haemonetics Corp.

Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.

CEO

Christopher Simon

Employees

2708

Headquarters

125 Summer Street
Boston, Massachusetts 02110
Phone: 17818487100
www.haemonetics.com

News

Haemonetics Stock: Executing Well, Valuation Concerns (NYSE:HAE)
Feb 16, 2023 02:00am

Haemonetics surpassed sell-side expectations with healthy revenue growth from Plasma and Hospital. Read why I think HAE stock merits a closer look.

Source:Seeking Alpha

Haemonetics Corporation (HAE) Q3 2023 Earnings Call Transcript
Feb 07, 2023 19:17pm

Haemonetics Corporation (NYSE:NYSE:HAE) Q3 2023 Earnings Conference Call February 7, 2023 8:00 AM ETCompany ParticipantsDavid Trenk - Manager, Investor RelationsChris Simon - Chief…

Source:Seeking Alpha

Haemonetics: Earnings Rate Of Change Justifies High Multiples (NYSE:HAE)
Feb 01, 2023 15:00pm

Haemonetics continues to catch a strong bid in FY23'' having clipped a 74% gain over the past 12 monts. See why we reiterate buy on HAE stock.

Source:Seeking Alpha